AltPep Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$52.9M
- Investors
-
9
AltPep General Information
Description
Operator of a proprietary peptide-based platform intended to diagnose and neutralize toxic precursors to amyloid diseases. The company's platform provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic, and anti-biofilm applications that focus on soluble oligomer binding assay for early detection of toxic oligomers in Alzheimer's disease, enabling healthcare institutes to improve human health through the early detection and treatment of amyloid diseases.
Contact Information
Website
www.altpep.comCorporate Office
- 1150 Eastlake Avenue East
- Suite 800
- Seattle, WA 98109
- United States
Corporate Office
- 1150 Eastlake Avenue East
- Suite 800
- Seattle, WA 98109
- United States
AltPep Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 22-Jun-2023 | $52.9M | Completed | Pre-Clinical Trials | ||
| 4. Early Stage VC (Series A) | 12-Jan-2021 | Completed | Startup | |||
| 3. Debt - General | 27-Sep-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 17-Apr-2019 | Completed | Startup | |||
| 1. Accelerator/Incubator | 08-Apr-2019 | Completed | Startup |
AltPep Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B Preferred | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 400,352 | $0.000100 | 8% | $1.25 | $1.25 | 1x | $1.25 | 1.1% |
| Series A-1 | 8,171,743 | $0.000100 | 8% | $2.53 | $2.53 | 1x | $2.53 | 22.45% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AltPep Comparisons
Industry
Financing
Details
AltPep Competitors (84)
One of AltPep’s 84 competitors is Alzheon, a Venture Capital-Backed company based in Framingham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Attralus | Venture Capital-Backed | Naples, FL | ||||
| Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Sirnaomics | Formerly VC-backed | Gaithersburg, MD | ||||
| Prevail Therapeutics | Formerly VC-backed | New York, NY |
AltPep Signals
AltPep Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eli Lilly and Company Foundation | Limited Partner | Minority | ||
| Gentium Partners | Accelerator/Incubator | Minority | ||
| Partners Investment | Venture Capital | Minority | ||
| S32 | Venture Capital | Minority | ||
| Senator Investment Group | Hedge Fund | Minority |
AltPep FAQs
-
When was AltPep founded?
AltPep was founded in 2018.
-
Where is AltPep headquartered?
AltPep is headquartered in Seattle, WA.
-
What is the size of AltPep?
AltPep has 33 total employees.
-
What industry is AltPep in?
AltPep’s primary industry is Drug Discovery.
-
Is AltPep a private or public company?
AltPep is a Private company.
-
What is the current valuation of AltPep?
The current valuation of AltPep is .
-
What is AltPep’s current revenue?
The current revenue for AltPep is .
-
How much funding has AltPep raised over time?
AltPep has raised $76M.
-
Who are AltPep’s investors?
Eli Lilly and Company Foundation, Gentium Partners, Partners Investment, S32, and Senator Investment Group are 5 of 9 investors who have invested in AltPep.
-
Who are AltPep’s competitors?
Alzheon, Attralus, Vedanta Biosciences, Sirnaomics, and Prevail Therapeutics are some of the 84 competitors of AltPep.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process